Unique ID issued by UMIN | UMIN000049611 |
---|---|
Receipt number | R000056128 |
Scientific Title | Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service |
Date of disclosure of the study information | 2023/12/01 |
Last modified on | 2022/11/16 10:51:28 |
Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service
Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service
Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service
Evaluation of task-extraction and acceptability of an artificial intelligence decision model for beginning a cancer risk-judgement service
Japan |
Healthy male/female adults
Adult |
Others
NO
In order to verify task-extractions and improvement of a cancer risk-decision artificial intelligence model, and an acceptability of the cancer risk-judgement service, for cancer therapy-completed subjects.
Others
In order to verify task-extractions and improvement of a cancer risk-decision artificial intelligence model, and an acceptability of the cancer risk-judgement service, for cancer therapy-completed subjects.
Blood-miRNA analysis, blood biochemical tests, hematologic tests, and Brief-type self-administrated Diet History Questionnaire (BDHQ)
Observational
20 | years-old | <= |
Not applicable |
Male and Female
(1) Healthy male/female subjects, not less than twenty years old at informed consent.
(2) Subjects being under the conditions described below:
Suffering from colon cancer, and for the duration of their follow-up period (except anticancer drug therapy) or completed their period.
Suffering from other cancers (except colon one), and for the duration of their follow-up period (except anticancer drug therapy).
(3) Subjects who can give informed consent to take part in this research, after being provided with an explanation of the protocol detail.
(1) Subjects being under some kind of continuous medical treatment (e.g., diabetes mellitus, heart/liver/kidney/mental disease).
(2) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.
30
1st name | Ryousuke |
Middle name | |
Last name | Matsuoka |
Kewpie Corporation
General Manager
182-0002
Sengawa Kewport 2-5-7 Sengawa-Cho, Chofu, Tokyo 182-0002, Japan
03-5384-7759
ryosuke_matsuoka@kewpie.co.jp
1st name | Masanori |
Middle name | |
Last name | Numa |
CPCC Company Limited
Clinical Planning Department
103-0021
4F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan
03-6225-9001
cpcc-contact@cpcc.co.jp
CPCC Company Limited
Kewpie Corporation
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan
03-6225-9005
IRB@cpcc.co.jp
NO
2023 | Year | 12 | Month | 01 | Day |
Unpublished
Preinitiation
2022 | Year | 09 | Month | 20 | Day |
2022 | Year | 09 | Month | 16 | Day |
2022 | Year | 12 | Month | 01 | Day |
2023 | Year | 02 | Month | 28 | Day |
This research is conducted to verify task-extractions and improvement of a cancer risk-decision artificial intelligence model, and an acceptability of the cancer risk-judgement service, for cancer therapy-completed subjects.
2022 | Year | 11 | Month | 25 | Day |
2022 | Year | 11 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056128
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |